Bessemer Group
KRYS icon

Bessemer Group’s Krystal Biotech KRYS Stock Holding History

Bessemer Group’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.24M Buy
20,285
+25
+0.1% +$6.65K 0.01% 471
2025
Q4 		$5M Buy
20,260
+20,111
+13,497% +$4.23M 0.01% 419
2025
Q3 		$26K Buy
149
+77
+107% +$11.5K ﹤0.01% 1619
2025
Q2 		$10K Buy
72
+3
+4% +$441 ﹤0.01% 1821
2025
Q1 		$12K Buy
69
+15
+28% +$2.52K ﹤0.01% 1706
2024
Q4 		$8K Sell
54
-18
-25% -$3.19K ﹤0.01% 1860
2024
Q3 		$13K Buy
72
+32
+80% +$6.17K ﹤0.01% 1600
2024
Q2 		$7K Buy
+40
New +$6.72K ﹤0.01% 1614
2020
Q3 		– Sell
-29,500
Closed -$1.22M – 1521
2020
Q2 		$1.22M Buy
29,500
+17,500
+146% +$842K ﹤0.01% 667
2020
Q1 		$519K Buy
+12,000
New +$628K ﹤0.01% 767

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return